Blood Plasma of Patients with Parkinson’s Disease Increases Alpha-Synuclein Aggregation and Neurotoxicity

A pathological hallmark of Parkinson’s disease (PD) is formation of Lewy bodies in neurons of the brain. This has been attributed to the spread of α-synuclein (α-syn) aggregates, which involves release of α-syn from a neuron and its reuptake by a neighboring neuron. We found that treatment with plas...

Full description

Saved in:
Bibliographic Details
Main Authors: Peng Wang, Xin Li, Xuran Li, Weiwei Yang, Shun Yu
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2016/7596482
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562787019128832
author Peng Wang
Xin Li
Xuran Li
Weiwei Yang
Shun Yu
author_facet Peng Wang
Xin Li
Xuran Li
Weiwei Yang
Shun Yu
author_sort Peng Wang
collection DOAJ
description A pathological hallmark of Parkinson’s disease (PD) is formation of Lewy bodies in neurons of the brain. This has been attributed to the spread of α-synuclein (α-syn) aggregates, which involves release of α-syn from a neuron and its reuptake by a neighboring neuron. We found that treatment with plasma from PD patients induced more α-syn phosphorylation and oligomerization than plasma from normal subjects (NS). Compared with NS plasma, PD plasma added to primary neuron cultures caused more cell death in the presence of extracellular α-syn. This was supported by the observations that phosphorylated α-syn oligomers entered neurons, rapidly increased accumulated thioflavin S-positive inclusions, and induced a series of metabolic changes that included activation of polo-like kinase 2, inhibition of glucocerebrosidase and protein phosphatase 2A, and reduction of ceramide levels, all of which have been shown to promote α-syn phosphorylation and aggregation. We also analyzed neurotoxicity of α-syn oligomers relative to plasma from different patients. Neurotoxicity was not related to age or gender of the patients. However, neurotoxicity was positively correlated with H&Y staging score. The modification in the plasma may promote spreading of α-syn aggregates via an alternative pathway and accelerate progression of PD.
format Article
id doaj-art-11fd01077ccd4c5690605d4827945d1c
institution Kabale University
issn 2090-8083
2042-0080
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-11fd01077ccd4c5690605d4827945d1c2025-02-03T01:21:48ZengWileyParkinson's Disease2090-80832042-00802016-01-01201610.1155/2016/75964827596482Blood Plasma of Patients with Parkinson’s Disease Increases Alpha-Synuclein Aggregation and NeurotoxicityPeng Wang0Xin Li1Xuran Li2Weiwei Yang3Shun Yu4Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, ChinaDepartment of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, ChinaDepartment of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, ChinaDepartment of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, ChinaDepartment of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, ChinaA pathological hallmark of Parkinson’s disease (PD) is formation of Lewy bodies in neurons of the brain. This has been attributed to the spread of α-synuclein (α-syn) aggregates, which involves release of α-syn from a neuron and its reuptake by a neighboring neuron. We found that treatment with plasma from PD patients induced more α-syn phosphorylation and oligomerization than plasma from normal subjects (NS). Compared with NS plasma, PD plasma added to primary neuron cultures caused more cell death in the presence of extracellular α-syn. This was supported by the observations that phosphorylated α-syn oligomers entered neurons, rapidly increased accumulated thioflavin S-positive inclusions, and induced a series of metabolic changes that included activation of polo-like kinase 2, inhibition of glucocerebrosidase and protein phosphatase 2A, and reduction of ceramide levels, all of which have been shown to promote α-syn phosphorylation and aggregation. We also analyzed neurotoxicity of α-syn oligomers relative to plasma from different patients. Neurotoxicity was not related to age or gender of the patients. However, neurotoxicity was positively correlated with H&Y staging score. The modification in the plasma may promote spreading of α-syn aggregates via an alternative pathway and accelerate progression of PD.http://dx.doi.org/10.1155/2016/7596482
spellingShingle Peng Wang
Xin Li
Xuran Li
Weiwei Yang
Shun Yu
Blood Plasma of Patients with Parkinson’s Disease Increases Alpha-Synuclein Aggregation and Neurotoxicity
Parkinson's Disease
title Blood Plasma of Patients with Parkinson’s Disease Increases Alpha-Synuclein Aggregation and Neurotoxicity
title_full Blood Plasma of Patients with Parkinson’s Disease Increases Alpha-Synuclein Aggregation and Neurotoxicity
title_fullStr Blood Plasma of Patients with Parkinson’s Disease Increases Alpha-Synuclein Aggregation and Neurotoxicity
title_full_unstemmed Blood Plasma of Patients with Parkinson’s Disease Increases Alpha-Synuclein Aggregation and Neurotoxicity
title_short Blood Plasma of Patients with Parkinson’s Disease Increases Alpha-Synuclein Aggregation and Neurotoxicity
title_sort blood plasma of patients with parkinson s disease increases alpha synuclein aggregation and neurotoxicity
url http://dx.doi.org/10.1155/2016/7596482
work_keys_str_mv AT pengwang bloodplasmaofpatientswithparkinsonsdiseaseincreasesalphasynucleinaggregationandneurotoxicity
AT xinli bloodplasmaofpatientswithparkinsonsdiseaseincreasesalphasynucleinaggregationandneurotoxicity
AT xuranli bloodplasmaofpatientswithparkinsonsdiseaseincreasesalphasynucleinaggregationandneurotoxicity
AT weiweiyang bloodplasmaofpatientswithparkinsonsdiseaseincreasesalphasynucleinaggregationandneurotoxicity
AT shunyu bloodplasmaofpatientswithparkinsonsdiseaseincreasesalphasynucleinaggregationandneurotoxicity